PowderJect Pharmaceuticals PLC has announced that following authorization by its shareholders at the company’s Extraordinary General Meeting on Friday September 29, it has completed its acquisition of Medeva’s vaccines business from Celltech Group Plc. The acquisition includes a range of marketed vaccines, which will be sold under the established Evans Vaccines brand, and one of Read more about PowderJect Completes Acquisition Of Medeva Vaccines[…]